Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

BASF Announces Leadership Changes in Nutrition and Health Divisions

(IN BRIEF) BASF has announced leadership changes in its Nutrition and Health divisions. Julia Raquet will assume responsibility for the Division Europe, Middle East, and Africa, while Dr. Martin Volland will take charge of the Division Nutrition & Health. These … Read the full press release

Aviva Research Highlights Need for Greater Awareness of Healthy Lifestyles and Cancer Prevention

(IN BRIEF) New research by Aviva reveals that there is still a need to raise awareness about the importance of leading a healthy lifestyle in cancer prevention. Over half of those surveyed hope cancer won’t happen to them, and 20% … Read the full press release

GSK’s Omjjara Receives EU Approval for Myelofibrosis Treatment

(IN BRIEF) GSK has received marketing authorization from the European Commission for Omjjara (momelotinib), an oral inhibitor targeting JAK1/JAK2 and activin A receptor type 1 (ACVR1). Omjjara is the first approved treatment in the EU for disease-related splenomegaly (enlarged spleen) … Read the full press release

GSK Seeks Regulatory Approval to Extend RSV Vaccination to At-Risk Adults Aged 50-59

(IN BRIEF) GSK has submitted a regulatory application to the European Medicines Agency (EMA) to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to adults aged 50-59 who are at increased risk for RSV disease. The … Read the full press release

Leadership Changes Announced in Merck Family Board Elections

(IN BRIEF) E. Merck KG, representing the Merck family’s interests in Merck KGaA, has disclosed the results of its regular board elections. Johannes Baillou, with 30 years of board experience at E. Merck KG, has been elected as Chairman of … Read the full press release

Merck Launches Digital Hub in Singapore to Drive Healthcare and Semiconductor Innovation

(IN BRIEF) Merck, a leading science and technology company, has inaugurated the Merck Digital Hub in Singapore, its first digital hub outside of the US and Europe. Supported by the Singapore Economic Development Board (EDB), the hub aims to accelerate … Read the full press release

Sanofi’s Dupixent Receives FDA Approval for Pediatric Eosinophilic Esophagitis (EoE) Treatment

(IN BRIEF) The U.S. Food and Drug Administration (FDA) has granted approval for Dupixent® (dupilumab) to treat pediatric patients aged 1 to 11 years, weighing at least 15 kg, who suffer from eosinophilic esophagitis (EoE). Dupixent is now the first … Read the full press release

Access to Community Perinatal Mental Health Teams Reduces Relapse Risk in Women with Severe Mental Illness After Childbirth

(IN BRIEF) New research conducted by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in collaboration with the University of Exeter, the London School of Hygiene & Tropical Medicine, and the University of Liverpool, reveals that … Read the full press release

University of Liverpool’s VISION Group Secures £569k to Improve Visual Impairment Care in Brain Injury and Neurological Conditions

(IN BRIEF) The University of Liverpool’s VISION group, focusing on visual impairment in acquired brain injury and neurological conditions, has received £569,000 in funding from the National Institute for Health and Care Research (NIHR). Led by Professor Fiona Rowe, the … Read the full press release

BioNTech and DualityBio Initiate Phase 3 Trial for HER2-Targeting ADC in Metastatic Breast Cancer

(IN BRIEF) BioNTech and Duality Biologics have announced the commencement of a pivotal Phase 3 trial for BNT323/DB-1303, a next-generation antibody-drug conjugate (ADC) targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in metastatic breast cancer. The trial will enroll … Read the full press release

Japan Approves Voydeya (danicopan), an Innovative Treatment for Paroxysmal Nocturnal Haemoglobinuria (PNH)

(IN BRIEF) The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Voydeya (danicopan), a groundbreaking oral Factor D inhibitor, for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). Voydeya is indicated in Japan for use in combination … Read the full press release

Basilea’s Antifungal Cresemba Sales in Latin America Trigger Milestone Payment from Partner Knight Therapeutics

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) has announced that its partner Knight Therapeutics Inc. (TSX: GUD) exceeded the sales threshold for the antifungal Cresemba (isavuconazole) in Latin America in 2023, triggering the first sales milestone payment for the region. … Read the full press release

University of Helsinki Study: Advancing Colorectal Cancer Risk Assessment with Comprehensive Genetic Information

(IN BRIEF) A study led by researchers at the University of Helsinki highlights the need for a more comprehensive approach to assessing the hereditary risk of colorectal cancer. By analyzing genetic data and health records of over 450,000 Finns, the … Read the full press release

Accenture Report Urges Business Leaders to Scale Generative AI by Redesigning Processes and Prioritizing Worker Well-Being

(IN BRIEF) Accenture’s latest report, “Work, workforce, workers: Reinvented in the age of generative AI,” emphasizes the need for business leaders to expand their focus beyond the impact of generative AI on specific tasks and roles. Instead, they should concentrate … Read the full press release

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release

Empa Researchers Develop Nanoparticle Soldering for Minimally Invasive Surgery

(IN BRIEF) Empa researchers have developed an innovative technique using nanoparticles for soldering wounds, potentially revolutionizing wound closure methods. This groundbreaking approach offers precise temperature control and can be applied in minimally invasive surgery. The nanoparticles enable gentle laser soldering, … Read the full press release

Prudential Appoints Arjan Toor as CEO Health to Drive Transformation and Customer Trust

(IN BRIEF) Prudential plc has announced the appointment of Arjan Toor as its new CEO Health, effective from February 1, 2024. This appointment is a significant step in Prudential’s strategic transformation, focusing on its Health business as one of its … Read the full press release

New Research Reveals Link Between High Blood Sugar and Upper Limb Problems

(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar levels and upper limb conditions such as frozen shoulder, Dupuytren’s disease, carpal tunnel syndrome, and trigger finger. The research, conducted … Read the full press release

Basilea Pharmaceutica Acquires Novel Antibiotics Program Targeting Multidrug-Resistant Gram-Negative Bacteria

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN), a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced an asset purchase agreement with Spexis AG (SIX: SPEX) for a preclinical antibiotics program aimed at combating Gram-negative bacteria, including … Read the full press release

University of Exeter Receives Multiple Athena Swan Awards for Gender Equality Commitment

(IN BRIEF) The University of Exeter has received recognition for its dedication to gender equality across various departments in the latest Athena Swan Charter Awards round. Five departments, including Health and Care Professions, University of Exeter Medical School, Ecology and … Read the full press release